🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/06/2015 | 55,26 | 56,17 | 55,26 | 55,91 | +1,17% | 1,66% | 7.797.644 |
| 17/06/2015 | 55,07 | 55,51 | 54,84 | 55,26 | +0,35% | 1,21% | 8.297.330 |
| 16/06/2015 | 54,62 | 55,09 | 54,27 | 55,07 | +1,03% | 1,49% | 7.303.407 |
| 15/06/2015 | 54,96 | 55,00 | 54,41 | 54,50 | -1,30% | 1,08% | 10.591.612 |
| 12/06/2015 | 56,10 | 56,11 | 55,14 | 55,22 | -1,77% | 1,72% | 16.571.290 |
| 11/06/2015 | 56,49 | 56,65 | 56,15 | 56,21 | -1,17% | 0,90% | 12.199.034 |
| 10/06/2015 | 56,28 | 56,93 | 56,21 | 56,88 | +1,31% | 1,27% | 10.713.914 |
| 09/06/2015 | 56,26 | 56,57 | 56,02 | 56,15 | -0,05% | 0,98% | 6.754.570 |
| 08/06/2015 | 56,19 | 56,46 | 56,07 | 56,17 | -0,20% | 0,70% | 8.434.094 |
| 05/06/2015 | 56,64 | 56,69 | 56,11 | 56,29 | -0,81% | 1,03% | 11.404.126 |
| 04/06/2015 | 57,21 | 57,45 | 56,56 | 56,75 | -1,52% | 1,57% | 11.350.154 |
| 03/06/2015 | 57,88 | 58,09 | 57,50 | 57,62 | +0,25% | 1,02% | 9.078.195 |
| 02/06/2015 | 57,68 | 57,69 | 57,08 | 57,48 | -0,84% | 1,06% | 9.424.664 |
| 01/06/2015 | 58,06 | 58,87 | 57,58 | 57,97 | -0,23% | 2,23% | 12.374.155 |
| 29/05/2015 | 57,14 | 58,32 | 56,75 | 58,10 | +1,99% | 2,76% | 20.976.349 |
| 28/05/2015 | 56,73 | 57,11 | 56,66 | 56,97 | +0,40% | 0,79% | 9.987.545 |
| 27/05/2015 | 56,38 | 57,04 | 56,17 | 56,74 | +0,83% | 1,54% | 10.193.582 |
| 26/05/2015 | 56,56 | 56,72 | 56,15 | 56,27 | -0,69% | 1,00% | 11.378.870 |
| 22/05/2015 | 57,32 | 57,32 | 56,62 | 56,66 | -1,20% | 1,22% | 9.421.939 |
| 21/05/2015 | 57,78 | 58,01 | 57,34 | 57,35 | -0,60% | 1,16% | 8.424.872 |
| 20/05/2015 | 57,89 | 58,06 | 57,67 | 57,69 | -0,10% | 0,68% | 6.324.575 |
| 19/05/2015 | 57,21 | 58,13 | 57,19 | 57,75 | +0,85% | 1,63% | 8.518.878 |
| 18/05/2015 | 57,41 | 57,68 | 57,26 | 57,26 | -0,37% | 0,73% | 7.535.539 |
| 15/05/2015 | 57,19 | 57,47 | 57,07 | 57,47 | +0,75% | 0,70% | 8.033.654 |
| 14/05/2015 | 56,75 | 57,15 | 56,35 | 57,04 | +1,01% | 1,41% | 7.469.410 |
| 13/05/2015 | 56,89 | 57,11 | 56,27 | 56,47 | -0,44% | 1,48% | 7.672.303 |
| 12/05/2015 | 56,82 | 56,99 | 56,40 | 56,72 | -0,93% | 1,04% | 13.825.111 |
| 11/05/2015 | 57,88 | 57,91 | 57,10 | 57,25 | -1,22% | 1,40% | 10.185.407 |
| 08/05/2015 | 58,21 | 58,57 | 57,92 | 57,96 | +0,73% | 1,11% | 10.630.283 |
| 07/05/2015 | 57,30 | 57,95 | 57,19 | 57,54 | +0,07% | 1,33% | 9.433.048 |